Intelligent Nanomedicine Institute, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei 230027, P. R. China.
Hefei National Laboratory for Physical Sciences at the Microscale Department of Chemical Physics, University of Science and Technology of China, Hefei 230026, P. R. China.
Nano Lett. 2023 Jun 28;23(12):5731-5737. doi: 10.1021/acs.nanolett.3c01484. Epub 2023 Jun 7.
Tumor metastasis remains the primary cause of treatment failure in cancer patients, and the high-sensitivity preoperative and intraoperative detection of occult micrometastases continues to pose a notorious challenge. Therefore, we have designed an albumin-hitchhiking near-infrared window II (NIR-II) fluorescence probe, IR1080, for the precise detection of micrometastases and subsequent fluorescence image-guided surgery. IR1080 rapidly covalently conjugates with albumin in plasma, resulting in a stronger fluorescence brightness upon binding. Moreover, the albumin-hitchhiked IR1080 has a high affinity for secreted protein acidic and rich in cysteine (SPARC), an albumin-binding protein that is overexpressed in micrometastases. The interaction between SPARC and IR1080-hitchhiked albumin enhances IR1080's capacity to track and anchor micrometastases, leading to a high detection rate and margin delineation ability, as well as a high tumor-to-normal tissue ratio. Therefore, IR1080 represents a highly efficient strategy for the diagnosis and image-guided resection surgery of micrometastases.
肿瘤转移仍然是癌症患者治疗失败的主要原因,而隐匿性微转移的高灵敏度术前和术中检测仍然是一个臭名昭著的挑战。因此,我们设计了一种白蛋白搭乘近红外窗口 II(NIR-II)荧光探针,IR1080,用于微转移的精确检测和随后的荧光图像引导手术。IR1080 与血浆中的白蛋白迅速共价结合,结合后荧光亮度更强。此外,与白蛋白搭乘的 IR1080 对富含半胱氨酸的分泌蛋白酸性(SPARC)具有高亲和力,SPARC 是微转移中过度表达的一种白蛋白结合蛋白。SPARC 与 IR1080 搭乘的白蛋白之间的相互作用增强了 IR1080 追踪和锚定微转移的能力,从而提高了检测率和边缘描绘能力,以及肿瘤与正常组织的高比值。因此,IR1080 代表了一种用于微转移的诊断和图像引导切除手术的高效策略。
Nano Lett. 2023-6-28
J Nanobiotechnology. 2023-11-2
Bioconjug Chem. 2018-10-23
Eur J Nucl Med Mol Imaging. 2022-11
Theranostics. 2022
Chem Biomed Imaging. 2025-3-4
Signal Transduct Target Ther. 2024-10-11